BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...

BD is investing $110 million to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its production of prefillable syringes, helping ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 ...

A company that formulates pharmaceuticals in a sterile environment is spending almost $30 million to expand its headquarters ...

A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

Bengaluru, Jan. 8 -- specialising in manufacturing generic injectable pharmaceuticals, focusing on complex sterile injectables, oncology, and ophthalmics, offering products in vials, pre-filled ...

LEE — Sharp Sterile Manufacturing announced a $28 million expansion of its site in Lee. The enhanced, state-of-the-art facility will strengthen opportunities for highly skilled engineering and ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...

Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines.

NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable self-administration, automation in fill–finish ...